The anti-tumor activity of MSCs in tumor models such as hepatoma and breast cancer has also been shown to result in downregulation of Akt, NF-kB and Wnt signaling pathways in the tumor cells [3]. This evidence concerns the gene NFKB1 and breast carcinoma.